
Strong 1-Year Survival Shown With MMUD Peripheral Blood Stem Cell Transplants
Overall survival (OS) at 1 year following mismatched unrelated donor (MMUD) peripheral blood stem cell transplantation in patients receiving myeloablative conditioning (MAC) and posttransplant cyclophosphamide (PTCy) was highly encouraging and comparable …